Artivion, INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NYSE
Artivion, Inc. announced its second quarter 2026 financial results, reporting an 11% increase in total revenues to $125.8 million, but a net loss of $13.5 million.
NYSE
Artivion reported strong first-quarter 2026 financial results, highlighted by an 18% revenue increase and the strategic acquisition of Endospan.
NYSE
Artivion, Inc. announced significant revenue growth and a substantial reduction in debt for the third quarter and first nine months of 2025, driven by strong product sales and strategic financial restructuring.
NYSE
Artivion, Inc. reported a 15% increase in total revenues for Q2 2025, reaching $113 million, while significantly reducing long-term debt through strategic financial maneuvers.
NYSE
Artivion's Q1 2025 results show a slight revenue increase but are impacted by a cybersecurity incident and changes in contingent consideration.
NYSE
Artivion's Q3 2024 results show revenue growth driven by key product lines, offset by a net loss and increased interest expenses due to recent debt refinancing.
NYSE
Artivion's Q2 2024 results show a revenue increase but a net loss, alongside strategic amendments to loan agreements.
NYSE
Artivion's first quarter of 2024 saw a significant revenue increase of 17% year-over-year, driven by growth in all product and service categories.